Search Trials
Conditions
Learn
About

Data source: ClinicalTrials.gov

This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.

Pomalidomide Plus Anti-CD20 Antibody and Prednisone in Frontline Indolent B-Cell Lymphoma | MicrobiomeTrials

← Back to trials

NCT07609446

Pomalidomide Plus Anti-CD20 Antibody and Prednisone in Frontline Indolent B-Cell Lymphoma

RecruitingOBSERVATIONAL

Trial Details

Start: 2026-05-01Est. Completion: 2027-04-30

Enrollment target: 30 participants

Locations

The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China

Contact

Haiwen Huanghuanghaiwen@suda.edu.cn 0512-80668050

Other microbiome trials you might be interested in

Zanubritnib and Anti-MAG NeuropathyPhase 2Recruiting

Anti-MAG IgM-associated Demyelinating Polyneuropathy

The MAZINGA study is a multicenter, open-label, single-arm Phase IIA clinical trial designed to evaluate the efficacy, s…

Milan, ItalyEst. completion Mar 2031

View Trial →

Axatilimab + CAR-T for High-Risk LymphomaPhase 1Recruiting

Diffuse Large B Cell Lymphoma (DLBCL)Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell LymphomaHigh-grade B-cell Lymphoma (HGBCL)High-Grade B-Cell Lymphoma, NosPMBCLFollicular Grade 3 Lymphoma

Axatilimab + CAR-T in High-Risk Lymphoma

Atlanta, United StatesEst. completion Dec 31, 2028

View Trial →

Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell MalignanciesPhase 1Recruiting

Hematologic Cancer

Non-Hodgkin's lymphoma (NHL) is a cancer that arises from the transformation of normal B and T lymphocytes (white blood …

Tempe, United StatesEst. completion Mar 2031

View Trial →

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.